Efficacy of a novel, orally active GSK-3 inhibitor 6-Methyl-N-[3-[[3-(1-methylethoxy)propyl]carbamoyl]-1H-pyrazol-4-yl]pyridine-3-carboxamide in tau transgenic mice

Autor: Uno, Yumiko, Iwashita, Hiroki, Tsukamoto, Tetsuya, Uchiyama, Noriko, Kawamoto, Tomohiro, Kori, Masakuni, Nakanishi, Atsushi
Zdroj: In Brain Research 2009 1296:148-163
Databáze: ScienceDirect